Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01981187
Title LGX818 for Patients With BRAFV600 Mutated Tumors
Acronym SIGNATURE
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Alabama Oncology St. Vincent's Birmingham Birmingham Alabama 35211 United States Details
Highlands Oncology Group Highlands Oncology Group (22) Fayetteville Arkansas 72703 United States Details
Yale University School of Medicine Smilow Cancer Hospital New Haven Connecticut 06520 United States Details
Whittingham Cancer Center Norwalk Hospital Norwalk Connecticut 06856 United States Details
Florida Cancer Specialists Florida Cancer Specialists (31 Fort Myers Florida 33901 United States Details
Lurie Children's Hospital of Chicago Developmental Therapeutics Chicago Illinois 60611 United States Details
Comprehensive Cancer Centers of Nevada CCC of Nevada (1) Las Vegas Nevada 89109 United States Details
Genesis Cancer Services Zanesville Ohio 43701 United States Details
University of Pennsylvania Presbyterian Medical Center University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sanford Research Sanford Health Sioux Falls South Dakota 57104 United States Details
Oncology Consultants Oncology Group Houston Texas 77024 United States Details
Utah Cancer Specialists Utah Cancer Specialists (11) Salt Lake City Utah 84106 United States Details
Shenandoah Oncology Shenadoah Oncology (2) Winchester Virginia 22601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field